![De novo 13q12.3-q14.11 deletion involving BRCA2 gene in a patient with developmental delay, elevated IgM levels,transient ataxia, and cerebellar hypoplasia, mimicking an A-T like phenotype De novo 13q12.3-q14.11 deletion involving BRCA2 gene in a patient with developmental delay, elevated IgM levels,transient ataxia, and cerebellar hypoplasia, mimicking an A-T like phenotype](https://data08.123doks.com/thumbv2/123dokorg/000/242/242530/cover.webp)
De novo 13q12.3-q14.11 deletion involving BRCA2 gene in a patient with developmental delay, elevated IgM levels,transient ataxia, and cerebellar hypoplasia, mimicking an A-T like phenotype
![Genetics and genomics in practice: The continuum from genetic disease to genetic information in health and disease - Genetics in Medicine Genetics and genomics in practice: The continuum from genetic disease to genetic information in health and disease - Genetics in Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/e6eabfad-53f6-41e1-b0c2-f995d6457157/fx1.jpg)
Genetics and genomics in practice: The continuum from genetic disease to genetic information in health and disease - Genetics in Medicine
![Overordnet overlevelse og kliniske egenskaber ved bugspytkirtelcancer hos BRCA mutationsbærere - britisk tidsskrift for kræft - Britisk tidsskrift for kræft 2022 Overordnet overlevelse og kliniske egenskaber ved bugspytkirtelcancer hos BRCA mutationsbærere - britisk tidsskrift for kræft - Britisk tidsskrift for kræft 2022](https://da.intermediapub.com/upload/british-journal-of-cancer/61/overall-survival-clinical-characteristics-pancreatic-cancer-brca-mutation-carriers.jpg)
Overordnet overlevelse og kliniske egenskaber ved bugspytkirtelcancer hos BRCA mutationsbærere - britisk tidsskrift for kræft - Britisk tidsskrift for kræft 2022
![Cancers | Free Full-Text | Analyzing the Opportunities to Target DNA Double-Strand Breaks Repair and Replicative Stress Responses to Improve Therapeutic Index of Colorectal Cancer | HTML Cancers | Free Full-Text | Analyzing the Opportunities to Target DNA Double-Strand Breaks Repair and Replicative Stress Responses to Improve Therapeutic Index of Colorectal Cancer | HTML](https://www.mdpi.com/cancers/cancers-13-03130/article_deploy/html/images/cancers-13-03130-g002.png)
Cancers | Free Full-Text | Analyzing the Opportunities to Target DNA Double-Strand Breaks Repair and Replicative Stress Responses to Improve Therapeutic Index of Colorectal Cancer | HTML
![Cancers | Free Full-Text | Analyzing the Opportunities to Target DNA Double-Strand Breaks Repair and Replicative Stress Responses to Improve Therapeutic Index of Colorectal Cancer | HTML Cancers | Free Full-Text | Analyzing the Opportunities to Target DNA Double-Strand Breaks Repair and Replicative Stress Responses to Improve Therapeutic Index of Colorectal Cancer | HTML](https://www.mdpi.com/cancers/cancers-13-03130/article_deploy/html/images/cancers-13-03130-g001.png)
Cancers | Free Full-Text | Analyzing the Opportunities to Target DNA Double-Strand Breaks Repair and Replicative Stress Responses to Improve Therapeutic Index of Colorectal Cancer | HTML
![DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers](https://data08.123doks.com/thumbv2/123dokorg/000/298/298393/cover.webp)
DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers
![Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA) Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)](https://data10.123doks.com/thumbv2/5dokorg/000/173/173629/cover.webp)
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)
![PDF) Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2 (CIMBA) PDF) Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2 (CIMBA)](https://www.researchgate.net/profile/Helena-Jernstroem/publication/38096580/figure/tbl2/AS:667677165113355@1536198049741/Number-of-BRCA1-and-BRCA2-mutation-carriers-by-study_Q320.jpg)